Vera Therapeutics, Inc.
VERA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,502,876 | $1,529,401 | $2,321,649 |
| - Cash | $57,773 | $49,121 | $55,090 | $92,646 |
| + Debt | $76,743 | $77,552 | $54,465 | $54,638 |
| Enterprise Value | – | $1,531,307 | $1,528,776 | $2,283,641 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$564 | -$563 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$77,769 | -$74,094 | -$49,817 | -$41,498 |
| % Margin | – | – | – | – |
| Net Income | -$80,293 | -$76,531 | -$51,694 | -$43,425 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.26 | -1.2 | -0.81 | -0.85 |
| % Growth | -5% | -48.1% | 4.7% | – |
| Operating Cash Flow | -$61,906 | -$54,798 | -$54,406 | -$39,182 |
| Capital Expenditures | -$133 | -$208 | -$187 | -$645 |
| Free Cash Flow | -$62,039 | -$55,006 | -$54,593 | -$39,827 |